US Stock MarketDetailed Quotes
TRVN Trevena
- 0.2380
- -0.0087-3.51%
Close Jul 19 16:00 ET
- 0.2468
- +0.0088+3.70%
Pre 08:13 ET
4.37MMarket Cap-87P/E (TTM)
0.2566High0.2377Low144.19KVolume0.2484Open0.2467Pre Close35.24KTurnover0.87%Turnover RatioLossP/E (Static)18.34MShares1.120052wk High-0.30P/B3.95MFloat Cap0.191052wk Low--Dividend TTM16.59MShs Float339.2500Historical High--Div YieldTTM7.66%Amplitude0.1910Historical Low0.2440Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Trevena Stock Forum
Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company dedicated to developing and commercializing innovative medicines for patients with central nervous system (CNS) disorders, has recently announced a amendment to its March 2022 ex-US royalty-based financing agreement with R-Bridge Healthcare Fund, L.P. (R-Bridge). This development repr...
Trevena Announces $2M Non-Dilutive Financing Tranche and Reduction in Outstanding Liabilities in Connection with Existing ex-US Royalty Financing
$Trevena(TRVN.US)$ 🚀🚀🚀🚀
Waiting game….
Trevena, Inc., a biopharmaceutical company listed on the Nasdaq under the ticker symbol TRVN, has announced compelling preclinical data from two collaborative research efforts aimed at understanding the efficacy of their novel therapeutic candidate, TRV045. These studies focus on chronic neuropathic pain and epilepsy, two complex cen...
Not gonna buy this lol.
High risk low reward.
🔥Definitely seeing a bounce.
🔥OVERSOLD!!!
🔥SIGNIFICANT Anti-Seizure Activity in Epilepsy Models!!!
No comment yet